Dr. J. Michael Mathis

Dr. J. Michael Mathis

Head of Academic Department/Faculty
LSU School of Veterinary Medicine, USA


Highest Degree
Ph.D. in Biochemistry from Louisiana State University, USA

Share this Profile

Area of Interest:

Chemistry
100%
Biochemistry
62%
Biophysics
90%
Endocrinology
75%
Oncology
55%

Selected Publications

  1. Williams, B.J., S. Bhatia, L.K. Adams, S. Boling and J.L. Carroll et al., 2012. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector. PloS One, Vol. 7. 10.1371/journal.pone.0046981.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Toomey, J.S., S. Bhatia, T.M. La'Wanda, E.A. Orchard and K.H. Tainter et al., 2012. PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133). PloS One, Vol. 7. 10.1371/journal.pone.0039041.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Chu, Q.D., G. Sun, M. Pope, N. Luraguiz and D.T. Curiel et al., 2012. Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model. Surgery, 152: 441-448.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Chaitanya, G.V., W. Cromer, S. Wells, M. Jennings, J.M. Mathis, A. Minagar and J.S. Alexander, 2012. Metabolic modulation of cytokine-induced brain endothelial adhesion molecule expression. Microcirculation, 19: 155-165.
    CrossRef  |  PubMed  |  Direct Link  |  

  5. Batra, V., Z. Syed, J.N. Gill, M.A. Coburn and P. Adegboyega et al., 2012. Effects of the tropical ginger compound,1'-acetoxychavicol acetate, against tumor promotion in K5.Stat3C transgenic mice. J. Exp. Clin. Cancer Res., 31: 57-57.
    CrossRef  |  PubMed  |  Direct Link  |  

  6. Mathis, J.M., S. Bhatia, A. Khandelwal, I. Kovesdi and S.J. Lokitz et al., 2011. Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging. PloS One, Vol. 6. 10.1371/journal.pone.0016792.
    CrossRef  |  PubMed  |  Direct Link  |  

  7. Cromer, W.E., J.M. Mathis, D.N. Granger, G.V. Chaitanya and J.S. Alexander, 2011. Role of the endothelium in inflammatory bowel diseases. World J. Gastroenterol., 17: 578-593.
    CrossRef  |  PubMed  |  Direct Link  |  

  8. Coburn, M.A., S. Brueggemann, S. Bhatia, B. Cheng and B.D. Li et al., 2011. Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea. Cancer Lett., 312: 82-90.
    CrossRef  |  PubMed  |  Direct Link  |  

  9. Chaitanya, G.V., W.E. Cromer, S.R. Wells, M.H. Jennings and P.O. Couraud et al., 2011. Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro. J. Neuroinflammation, Vol. 8. 10.1186/1742-2094-8-162.
    CrossRef  |  PubMed  |  Direct Link  |  

  10. Veluswamy, H., K. Suryawala, A. Sheth, S. Wells and E. Salvatierra et al., 2010. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol., Vol. 10. 10.1186/1471-230X-10-104.
    CrossRef  |  PubMed  |  Direct Link  |  

  11. Short, J.J., A.A. Rivera, H. Wu, M.R. Walter, M. Yamamoto, J.M. Mathis and D.T. Curiel, 2010. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Mol. Cancer Therapeutics, 9: 2536-2544.
    CrossRef  |  PubMed  |  Direct Link  |  

  12. Pennington, K., Q.D. Chu, D.T. Curiel, B.D. Li and J.M. Mathis, 2010. The utility of a tissue slice model system to determine breast cancer infectivity by oncolytic adenoviruses. J. Surgical Res., 163: 270-275.
    CrossRef  |  PubMed  |  Direct Link  |  

  13. Kleiner-Hancock, H.E., R. Shi, A. Remeika, D. Robbins and M. Prince et al., 2010. Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts. BMC Cancer, Vol. 10. 10.1186/1471-2407-10-394.
    CrossRef  |  PubMed  |  Direct Link  |  

  14. Ganta, V.C., W. Cromer, G.L. Mills, J. Traylor and M. Jennings et al., 2010. Angiopoietin-2 in experimental colitis. Inflammatory Bowel Dis., 16: 1029-1039.
    CrossRef  |  PubMed  |  Direct Link  |  

  15. Davis, J.N., D. Rogers, L. Adams, T. Yong and J.S. Jung et al., 2010. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells. J. Cellular Physiol., 225: 875-887.
    CrossRef  |  PubMed  |  Direct Link  |  

  16. Cromer, W., M.H. Jennings, Y. Odaka, J. Michael Mathis and J. Steven Alexander, 2010. Murine rVEGF164b, an Inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction. Microcirculation, 17: 536-547.
    CrossRef  |  PubMed  |  Direct Link  |  

  17. Chaitanya, G.V., S.E. Franks, W. Cromer, S.R. Wells and M. Bienkowska et al., 2010. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphatic Res. Biol., 8: 155-164.
    CrossRef  |  PubMed  |  Direct Link  |  

  18. Becks, L., M. Prince, H. Burson, C. Christophe and M. Broadway et al., 2010. Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene. BMC Cancer, Vol. 10. 10.1186/1471-2407-10-540.
    CrossRef  |  PubMed  |  Direct Link  |  

  19. Balyasnikova, I.V., R. Franco‐Gou, J.M. Mathis and M.S. Lesniak, 2010. Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface. J. Tissue Eng. Regenerative Med., 4: 247-258.
    CrossRef  |  PubMed  |  Direct Link  |  

  20. Stoff, A., A.A. Rivera, N. Sanjib Banerjee, S.T. Moore and T. Michael Numnum et al., 2009. Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp. Dermatol., 18: 362-369.
    CrossRef  |  PubMed  |  Direct Link  |  

  21. Li, X.L., Y.Y. Liu, D. Knight, Y. Odaka and J.M. Mathis et al., 2009. Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression. PloS One, Vol. 4. 10.1371/journal.pone.0006385.
    CrossRef  |  PubMed  |  Direct Link  |  

  22. Li, X.L., D. Zhang, D. Knight, Y. Odaka, J. Glass, J.M. Mathis and Q.J. Zhang, 2009. Priming of immune responses against transporter associated with antigen processing (TAP)‐deficient tumours: Tumour direct priming. Immunology, 128: 420-428.
    CrossRef  |  PubMed  |  Direct Link  |  

  23. Kleiner, H.E., P. Krishnan, J. Tubbs, M. Smith and C. Meschonat et al., 2009. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. J. Exp. Clin. Cancer Res., 28: 54-54.
    CrossRef  |  PubMed  |  Direct Link  |  

  24. Zhang, Q.J., X.L. Li, D. Wang, X.C. Huang and J.M. Mathis et al., 2008. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. PloS One, Vol. 3. 10.1371/journal.pone.0003097.
    CrossRef  |  PubMed  |  Direct Link  |  

  25. Stoff-Khalili, M.A., A.A. Rivera, A. Nedeljkovic-Kurepa, A. DeBenedetti and X.L. Li et al., 2008. Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Rese. Treatment, 108: 43-55.
    CrossRef  |  PubMed  |  Direct Link  |  

  26. Sonabend, A.M., I.V. Ulasov, M.A. Tyler, A.A. Rivera, J.M. Mathis and M.S. Lesniak, 2008. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells, 26: 831-841.
    CrossRef  |  PubMed  |  Direct Link  |  

  27. Siegele, B., C. Cefalu, N. Holm, G. Sun and J. Tubbs et al., 2008. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival. J. Surgical Res., 148: 83-89.
    CrossRef  |  PubMed  |  Direct Link  |  

  28. Li, X.L., D.Q. Zhang, D. Wang, D.S. Knight and L. Yin et al., 2008. In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity. Tumor Biol., 29: 359-370.
    CrossRef  |  PubMed  |  Direct Link  |  

  29. Zhu, Z.B., J.M. Mathis, S.K. Makhija, B. Lu and M. Wang et al., 2007. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck. Int. J. Oncol., 31: 1213-1222.
    CrossRef  |  PubMed  |  Direct Link  |  

  30. Ulasov, I.V., A.A. Rivera, D.M. Nettelbeck, L.B. Rivera and J.M. Mathis et al., 2007. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy. Int. J. Oncol., 31: 1177-1185.
    CrossRef  |  PubMed  |  Direct Link  |  

  31. Stoff-Khalili, M.A., A.A. Rivera, J.M. Mathis, N.S. Banerjee and A.S. Moon et al., 2007. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res. Treatment, 105: 157-167.
    CrossRef  |  PubMed  |  Direct Link  |  

  32. Stoff, A., A.A. Rivera, J.M. Mathis, S.T. Moore and N.S. Banerjee et al., 2007. Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J. Mol. Med., 85: 481-496.
    CrossRef  |  PubMed  |  Direct Link  |  

  33. Stoff‐Khalili, M.A., A.A. Rivera, A. Stoff, J.M. Mathis and R.P. Rocconi et al., 2007. Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer. Int. J. Cancer, 120: 935-941.
    CrossRef  |  PubMed  |  Direct Link  |  

  34. Jiang, B., V.Y. Hebert, Y. Li, J.M. Mathis, J.S. Alexander and T.R. Dugas, 2007. HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis. Toxicol. Applied Pharmacol., 224: 60-71.
    CrossRef  |  PubMed  |  Direct Link  |  

  35. Holm, N.T., K. Byrnes, B.D. Li, R.H. Turnage, F. Abreo, J.M. Mathis and Q.D. Chu, 2007. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence. J. Surgical Res., 141: 53-59.
    CrossRef  |  PubMed  |  Direct Link  |  

  36. Chu, Q.D., L. Sun, J. Li, K. Byrnes and D. Chervenak et al., 2007. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir. J. Surgical Res., 143: 189-194.
    CrossRef  |  PubMed  |  Direct Link  |  

  37. Byrnes, K., B.D. Li, N. Holm, J. Li and Y. Okadata et al., 2007. A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival in a rat peritoneal carcinomatosis model. Surgery, 142: 270-275.
    CrossRef  |  PubMed  |  Direct Link  |  

  38. Alexander, J.S., J.M. Mathis and K. Pruitt, 2007. Interaction of microsatellite instability and loss of heterozygosity in adenocarcinoma: Multiple markers in adenocarcinoma: An introduction to 'Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA'. Eur. J. Gastroenterol. Hepatol., 19: 1038-1040.
    CrossRef  |  PubMed  |  Direct Link  |  

  39. Strat, A., L. Gao, T. Utsuki, B. Cheng and S. Nuthalapaty et al., 2006. Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs. Nucleic Acids Res., 34: 3803-3810.
    CrossRef  |  PubMed  |  Direct Link  |  

  40. Stoff-Khalili, M.A., A.A. Rivera, L.P. Le, A. Stoff and M. Everts et al., 2006. Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents. Cancer Gene Therapy, 13: 606-618.
    CrossRef  |  PubMed  |  Direct Link  |  

  41. Stoff, A., A.A. Rivera, N.S. Banerjee, J. Michael Mathis, A. Espinosa‐de‐los‐Monteros et al., 2006. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regeneration, 14: 608-617.
    CrossRef  |  PubMed  |  Direct Link  |  

  42. Matthews, Q.L., D.A. Sibley, H. Wu, J. Li and M.A. Stoff-Khalili et al., 2006. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion. Mol. Imag., 5: 510-519.
    PubMed  |  

  43. Mathis, J.M., P.L. Stewart, Z.B. Zhu and D.T. Curiel, 2006. Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism. Clin. Cancer Res., 12: 2651-2656.
    CrossRef  |  PubMed  |  Direct Link  |  

  44. Mathis, J.M., B.J. Williams, D.A. Sibley, J.L. Carroll and J. Li et al., 2006. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control. J. Gene Med., 8: 1105-1120.
    CrossRef  |  PubMed  |  Direct Link  |  

  45. Stoff-Khalili, M.A., A.A. Rivera, J.N. Glasgow, L.P. Le and A. Stoff et al., 2005. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Gene Therapy, 12: 1696-1706.
    CrossRef  |  PubMed  |  Direct Link  |  

  46. Stoff-Khalili, M.A., A. Stoff, A.A. Rivera, N.S. Banerjee and M. Everts et al., 2005. Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system. Breast Cancer Res., 7: R1141-R1152.
    CrossRef  |  PubMed  |  Direct Link  |  

  47. Stoff-Khalili, M.A., A. Stoff, A.A. Rivera, J.M. Mathis and M. Everts et al., 2005. Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Cancer Boil. Therapy, 4: 1203-1210.
    CrossRef  |  PubMed  |  Direct Link  |  

  48. Sasaki, M., J.M. Mathis, M.H. Jennings, P. Jordan and Y. Wang et al., 2005. Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. J. Inflammation, Vol. 2. 10.1186/1476-9255-2-13.
    CrossRef  |  PubMed  |  Direct Link  |  

  49. Mathis, J.M., M.A. Stoff-Khalili and D.T. Curiel, 2005. Oncolytic adenoviruses-selective retargeting to tumor cells. Oncogene, 24: 7775-7791.
    CrossRef  |  Direct Link  |  

  50. Mathis, J.M. and A. DeBenedetti, 2005. Control of protein translation in cancer therapy. Sci. Med., 10: 74-77.

  51. Li, J., L. Le, D.A. Sibley, J.M. Mathis and D.T. Curiel, 2005. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion. Virology, 338: 247-258.
    CrossRef  |  PubMed  |  Direct Link  |  

  52. Pezzi, V., J.M. Mathis, W.E. Rainey and B.R. Carr, 2003. Profiling transcript levels for steroidogenic enzymes in fetal tissues. J. Steroid Biochem. Mol. Boil., 87: 181-189.
    CrossRef  |  PubMed  |  Direct Link  |  

  53. Kolomytkin, O.V., A.A. Marino, D.D. Waddell, J.M. Mathis, R.E. Wolf, K.K. Sadasivan and J.A. Albright, 2002. IL-1β-induced production of metalloproteinases by synovial cells depends on gap junction conductance. Am. J. Physiol. Cell. Physiol., 282: 1254-1260.
    CrossRef  |  PubMed  |  Direct Link  |  

  54. Fallo, F., V. Pezzi, L. Barzon, P. Mulatero, F. Veglio, N. Sonino and J.M. Mathis, 2002. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur. J. Endocrinol., 147: 795-802.
    CrossRef  |  PubMed  |  Direct Link  |  

  55. Virmani, A.K., C. Muller, A. Rathi, S. Zoechbauer-Mueller, M. Mathis and A.F. Gazdar, 2001. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res., 7: 584-589.
    PubMed  |  Direct Link  |  

  56. Carroll, J.L., L.L. Nielsen, S.B. Pruett and J.M. Mathis, 2001. The role of natural killer cells in adenovirus-mediated p53 gene therapy. Mol. Cancer Ther., 1: 49-60.
    PubMed  |  Direct Link  |  

  57. Bell, M.C., S.A. Davidson, J.M. Mathis and F. Ampil, 2001. Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: A phase I trial. Gynecol. Oncol., 80: 128-131.
    CrossRef  |  PubMed  |  Direct Link  |  

  58. Nielsen, L.L., M. Gurnani, B. Shi, G. Terracina and R.C. Johnson et al., 2000. Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: Utility in the development of novel cancer therapeutics. Cancer Res., 60: 7066-7074.
    PubMed  |  Direct Link  |  

  59. Bell, M.C., P. Crowley-Nowick, H.L. Bradlow, D.W. Sepkovic and D. Schmidt-Grimminger et al., 2000. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol., 78: 123-129.
    CrossRef  |  PubMed  |  Direct Link  |  

  60. Von Gruenigen, V.E., J.D. O'boyle, R.L. Coleman, D. Wilson, D.S. Miller and J.M. Mathis, 1999. Efficacy of intraperitoneal adenovirus-mediated p53 gene therapy in ovarian cancer. Int. J. Gynecol. Cancer, 9: 365-372.
    CrossRef  |  PubMed  |  Direct Link  |  

  61. Lavranos, T.C., J.M. Mathis, S.E. Latham, B. Kalionis, J.W. Shay and R.J. Rodgers, 1999. Evidence for ovarian granulosa stem cells: Telomerase activity and localization of the telomerase ribonucleic acid component in bovine ovarian follicles. Biol. Reproduction, 61: 358-366.
    CrossRef  |  PubMed  |  Direct Link  |  

  62. Von Gruenigen, V.E., J.T. Santoso, R.L. Coleman, C.Y. Muller, D.S. Miller and J.M. Mathis, 1998. In Vivo studies of adenovirus-based p53 gene therapy for ovarian cancer. Gynecol. Oncol., 69: 197-204.
    CrossRef  |  PubMed  |  Direct Link  |  

  63. Thai, T.H., F. Du, J.T. Tsan, Y. Jin and A. Phung et al., 1998. Mutations in the BRCAI-Associated RING Domain (BARD1) gene in primary breast, ovarian and uterine cancers. Human Mol. Genet., 7: 195-202.
    CrossRef  |  PubMed  |  Direct Link  |  

  64. Santoso, J.T., J.A. Lucci, R.L. Coleman, S. Hatch, P. Wong, D. Miller and J.M. Mathis, 1998. Does glutamine supplementation increase radioresistance in squamous cell carcinoma of the cervix? Gynecol. Oncol., 71: 359-363.
    CrossRef  |  PubMed  |  Direct Link  |  

  65. Pezzi, V., C.D. Clyne, S. Ando, J.M. Mathis and W.E. Rainey, 1997. Ca2+-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases. Endocrinology, 138: 835-838.
    CrossRef  |  PubMed  |  Direct Link  |  

  66. Clyne, C.D., Y. Zhang, L. Slutsker, J.M. Mathis, P.C. White and W.E. Rainey, 1997. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol. Endocrinol., 11: 638-649.
    CrossRef  |  PubMed  |  Direct Link  |  

  67. Kutteh, W.H., D.S. Miller and J.M. Mathis, 1996. Immunologic characterization of tumor markers in human ovarian cancer cell lines. J. Soc. Gynecol. Investigation, 3: 216-222.
    PubMed  |  Direct Link  |  

  68. Denner, K., W.E. Rainey, V. Pezzi, I.M. Bird, R. Bernhardt and J.M. Mathis, 1996. Differential regulation of 11β-hydroxylase and aldosterone synthase in human adrenocortical H295R cells. Mol. Cell. Endocrinol., 121: 87-91.
    CrossRef  |  Direct Link  |  

  69. Santoso, J.T., D.C. Tang, S.B. Lane, J. Hung and D.J. Reed et al., 1995. Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol. Oncol., 59: 171-178.
    CrossRef  |  PubMed  |  Direct Link  |  

  70. Myeroff, L.L., R. Parsons, S.J. Kim, L. Hedrick and K.R. Cho et al., 1995. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547.
    PubMed  |  Direct Link  |  

  71. Bird, I.M., J.M. Mathis, J.I. Mason and W.E. Rainey, 1995. Ca(2+)-regulated expression of steroid hydroxylases in H295R human adrenocortical cells. Endocrinology, 136: 5677-5684.
    CrossRef  |  PubMed  |  Direct Link  |  

  72. Barnea, A., G. Cho, G. Lu and M. Mathis, 1995. Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y-producing neurons. J. Neurosci. Res., 42: 638-647.
    CrossRef  |  PubMed  |  Direct Link  |  

  73. Rainey, W.H., C. Sawetawan, J.W. Shay, M.D. Michael and J.M. Mathis et al., 1994. Transformation of human granulosa cells with the E6 and E7 regions of human papillomavirus. J. Clin. Endocrinol. Metab., 78: 705-710.
    CrossRef  |  PubMed  |  Direct Link  |  

  74. Orth, K., J. Hung, A. Gazdar, M. Mathis, A. Bowcock and J. Sambrook, 1994. Ovarian tumors display persistent microsatellite instability caused by mutation in the mismatch repair gene hMSH-2. Cold Spring Harbor Symp Quantitative Boil., 59: 349-356.
    CrossRef  |  PubMed  |  Direct Link  |  

  75. Orth, K., J. Hung, A. Gazdar, A. Bowcock, J.M. Mathis and J. Sambrook, 1994. Genetic instability in human ovarian cancer cell lines. Proc. Nat. Acad. Sci., 91: 9495-9499.
    PubMed  |  Direct Link  |  

  76. Holland, O.B., J.M. Mathis, I.M. Bird and W.E. Rainey, 1993. Angiotensin increases aldosterone synthase mRNA levels in human NCI-H295 cells. Mol. Cell. Endocrinol., 94: R9-R13.
    CrossRef  |  PubMed  |  Direct Link  |  

  77. Bird, I.M., N.A. Hanley, R.A. Word, J.M. Mathis, J.L. McCarthy, J.I. Mason and W.E. Rainey, 1993. Human NCI-H295 adrenocortical carcinoma cells: A model for angiotensin-II-responsive aldosterone secretion. Endocrinology, 133: 1555-1561.
    CrossRef  |  PubMed  |  Direct Link  |  

  78. Mathis, J.M., D.M. Simmons, X. He, L.W. Swanson and M.G. Rosenfeld, 1992. Brain 4: A novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression. EMBO J., 11: 2551-2561.
    PubMed  |  

  79. Kapiloff, M.S., J.M. Mathis, C.A. Nelson, C.R. Lin and M.G. Rosenfeld, 1991. Calcium/calmodulin-dependent protein kinase mediates a pathway for transcriptional regulation. Proc. Nat. Acad. Sci., 88: 3710-3714.
    CrossRef  |  PubMed  |  Direct Link  |  

  80. Prough, R.A., A.J. Sherratt, D.E. Banet, M.W. Linder, J.M. Mathis and E.R. Simpson, 1989. Modulation of the polycycuc aromatic hydrocarbon-dependent induction of cytochrome P450ia1 by glucocorticoids. Drug Metab. Rev., 20: 585-599.
    CrossRef  |  PubMed  |  Direct Link  |  

  81. Means, G.D., M.S. Mahendroo, C.J. Corbin, J.M. Mathis, F.E. Powell, C. Mendelson and E. Simpson, 1989. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem., 264: 19385-19391.
    Direct Link  |  

  82. Mathis, J.M., W.H. Houser, E. Bresnick, J.A. Cidlowski, R.N. Hines, R.A. Prough and E.R. Simpson, 1989. Glucocorticoid regulation of the rat cytochrome P450c (P450IA1) gene: Receptor binding within intron I. Arch. Biochem. Biophys., 269: 93-105.
    CrossRef  |  PubMed  |  Direct Link  |  

  83. Hines, R.N., J.M. Mathis and C.S. Jacob, 1988. Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis, 9: 1599-1605.
    CrossRef  |  PubMed  |  Direct Link  |  

  84. Mathis, J.M., Prough, R.A., R.N. Hines, E. Bresnick and E.R. Simpson, 1986. Regulation of cytochrome P-450c by glucocorticoids and polycyclic aromatic hydrocarbons in cultured fetal rat hepatocytes. Arch. Biochem. Biophys., 246: 439-448.
    CrossRef  |  PubMed  |  Direct Link  |  

  85. Wiebkin, P., J.H. Dees, J.M. Mathis and R.A. Prough, 1985. Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture. Drug Metab. Disposition, 13: 163-168.
    PubMed  |  Direct Link  |  

  86. Mathis, J.M., J.D. Johnston, P.C. Macdonald and M. Linette Casey, 1983. Steroid 21-sulfatase activity in human placenta. J. Steroid Biochem., 18: 575-579.
    CrossRef  |  PubMed  |  Direct Link  |  

  87. Garrard, L.J., J.M. Mathis and F.M. Raushel, 1983. Substrate-induced inactivation of argininosuccinate lyase by monofluorofumarate and difluorofumarate. Biochemistry, 22: 3729-3735.
    CrossRef  |  PubMed  |  Direct Link  |